[조사자료] 세계의 포유류 폴리클로널 IgG 항체 시장 (2023~2030) : 마우스, 토끼

■ 영문 제목 : Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application (Western Blotting, ELISA), By End-user, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23MR116 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 2월 ■ 페이지수 : 180 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 포유류 폴리클로널 IgG 항체 시장 규모가 2023년부터 2030년 사이에 CAGR 5.01% 증가하여, 2030년에는 16.7억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의 포유류 폴리클로널 IgG 항체 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 산업 전망, 종류별 (염소, 토끼, 말, 마우스, 기타) 분석, 제품별 (심장 바이오마커, 대사 바이오마커, 신장 바이오마커, 기타) 분석, 용도별 (ELISA법, 면역 탁도법, 면역 전기 영동법, 웨스턴 블로팅법) 분석, 최종 용도별 (병원, 진단 센터, 학술 및 연구 센터) 분석, 지역 별 (북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카) 분석, 경쟁 현황 등의 내용을 수록하고 있습니다. 또한 본 리포트는 Abcam plc., Bio -Rad Laboratories, Thermo Fisher Scientific, Novartis AG, Geno Technology Inc., Merck KGaA, Cell Signaling Technologies, F. Hoffmann -La Roche Ltd, Stemcell Technologies Inc., Phoenix Pharmaceuticals 등의 기업 정보가 포함되어 있습니다.
・조사 방법 및 범위
・개요
・산업 전망
・세계의 포유류 폴리클로널 IgG 항체 시장 규모 : 종류별
- 염소의 시장 규모
- 토끼의 시장 규모
- 말의 시장 규모
- 마우스의 시장 규모
- 다른 종류의 시장 규모
・세계의 포유류 폴리클로널 IgG 항체 시장 규모 : 제품별
- 심장 바이오마커의 시장 규모
- 대사 바이오마커의 시장 규모
- 신장 바이오마커의 시장 규모
- 기타 포유류 폴리클로널 IgG 항체의 시장 규모
・세계의 포유류 폴리클로널 IgG 항체 시장 규모 : 용도별
- ELISA에 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
- 면역 탁도법에 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
- 면역 전기 영동법에 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
- 웨스턴 블로팅법에 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
・세계의 포유류 폴리클로널 IgG 항체 시장 규모 : 최종 용도별
- 병원에서 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
- 진단 센터에서 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
- 학술 및 연구 센터에서 사용되는 포유류 폴리클로널 IgG 항체의 시장 규모
・세계의 포유류 폴리클로널 IgG 항체 시장 규모 : 지역별
- 북미의 포유류 폴리클로널 IgG 항체 시장 규모
- 유럽의 포유류 폴리클로널 IgG 항체 시장 규모
- 아시아 태평양의 포유류 폴리클로널 IgG 항체 시장 규모
- 중남미의 포유류 폴리클로널 IgG 항체 시장 규모
- 중동 및 아프리카의 포유류 폴리클로널 IgG 항체 시장 규모
・경쟁 현황

■ 보고서 개요

Mammalian Polyclonal IgG Antibody Market Growth & Trends

The global mammalian polyclonal IgG antibody market size is expected to reach USD 1.67 billion by 2030, registering a CAGR of 5.01% of the overall revenue, according to a new report by Grand View Research, Inc. The industry has witnessed significant growth owing to the development of innovative drugs and increasing government initiatives. Pharma and biotech companies are indulging in rigorous research and development since the antibody-drug conjugate is considered to be the fastest-growing field of the pharmaceutical market.In October 2022, SAB Biotherapeutics announced an exclusive partnership with Emergent BioSolutions Inc. According to the agreement, Emergent BioSolutions is expected to offer end-to-end services of Contract Development and Manufacturing (CDMO) to produce polyclonal antibody-based products.

The partnership will enable SAB Biotherapeutics to primarily focus on the research and development of the polyclonal antibody drug pipeline. As of October 2022, the company is conducting various clinical-stage programs in the treatment of influenza, acute and recurrent C. diff., Type 1 diabetes and researching potential candidates in oncology and immunology. The COVID-19 pandemic surged the use of polyclonal antibodies across the globe. For instance, in July 2022, GigaGen Inc. announced the publication of research showcasing its studies of GIGA-2050, recombinant polyclonal antibodies for COVID-19. According to the research, the GIGA-2050 has an effective manufacturing approach to treating infectious diseases by targeting numerous viral epitopes.

The company has leveraged its existing technology to develop medicines for infectious diseases. Key companies are continuously expanding their product and service portfolios to accelerate the development and manufacturing of the product. For instance, in October 2022, Amerigo Scientific, a distributor, introduced its recent development of polyclonal antibodies to human blood coagulation factor XIII to assist professionals in the area of life science for detecting blood coagulation factor XIII. However, the product is solely for research purposes and not for therapeutic or diagnostics. The development of this product is expected to strengthen the company’s position in biomedical research applications.

Mammalian Polyclonal IgG Antibody Market Report Highlights

• Based ontypes, the mouse segment is expected to register the fastest CAGR during the forecast period. The growth is attributed to the similar characteristic of its immune system as humans, resulting in low variation of the outcome during the trials

• Basedon products, the metabolic biomarkers segment captured the largest share in 2022 due to the high incidence of chronic diseases

• The ELISA applicationsegment is estimated to hold the largest share by2030. As it offers more accurate diagnoses of diseases, such as AIDS, Lyme disease, Rocky Mountain spotted fever, chickenpox, squamous cell carcinoma, syphilis, shingles, and other infections, than other antibody-based assays.

• The pharma & biotech companies end-user segment held the highest share in 2022and is likely to remain dominant over the forecast period

• Companies are focusing on the adoption of smarter, novel, and advanced approaches for the development of new diagnostic tests & drugs

• North America dominated the industry in 2022 due to the presence of prominent players, advanced healthcare infrastructure, and high healthcare expenditure

• Asia Pacific is expected to register the fastest CAGR over the forecast period due to untapped opportunities, rising healthcare expenditure, and the growing regional presence of major global players

■ 보고서 목차

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecasts Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Sample Size For The Study On Personalized Nutrition & Supplements Market
1.3.5.1 Primary Sources
1.3.5.2 Details Of Primary Research
1.3.5.3 Secondary Data Sources
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Market Model
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Trends And Outlook
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related Market Outlook
3.3 Penetration & Growth Prospect Mapping, 2022
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Advantages Over Monoclonal Antibodies
3.4.1.2 Rising R&D Investments
3.4.1.3 Increasing Adoption Of Novel Diagnostic Procedures
3.4.2 Market Restraint Analysis
3.4.2.1 Stringent Regulatory Policies
3.5 Business Environment Analysis
3.5.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.5.2 Porter’s Five Forces Analysis
3.6 Covid-19 Impact Analysis
Chapter 4 Type Business Analysis
4.1 Mammalian Polyclonal Igg Antibody Market: Type Movement Analysis
4.2 Goat
4.2.1 Goat Market Estimates And Forecast For 2018 – 2030 (USD Million)
4.3 Rabbit
4.3.1 Rabbit Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Horse
4.4.1 Horse Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5 Mouse
4.5.1 Mouse Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.6 Others
4.6.1 Others Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Product Business Analysis
5.1 Mammalian Polyclonal Igg Antibody Market: Product Movement Analysis
5.2 Cardiac Biomarkers
5.2.1 Cardiac Biomarkers Market Estimates And Forecast For 2018 – 2030 (USD Million)
5.3 Metabolic Biomarkers
5.3.1 Metabolic Biomarkers Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Renal Biomarkers
5.4.1 Renal Biomarkers Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.5 Other
5.5.1 Other Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Mammalian Polyclonal Igg Antibody Market: Application Movement Analysis
6.2 Elisa
6.2.1 Elisa Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Immunoturbidimetry
6.3.1 Immunoturbidimetry Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Immunoelectrophoresis
6.4.1 Immunoelectrophoresis Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Antibody Identification
6.5.1 Antibody Identification Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Immunohistochemistry
6.6.1 Immunohistochemistry Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Immunocytochemistry
6.7.1 Immunocytochemistry Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Western Blotting
6.6.1 Western Blotting Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 End-Users Business Analysis
7.1 Mammalian Polyclonal Igg Antibody Market: End-Users Movement Analysis
7.2 Pharmaceutical And Biotechnology Companies
7.2.2 Pharmaceutical And Biotechnology Companies Market Estimates And Forecast For 2018 – 2030 (USD Million)
7.3 Hospitals
7.3.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4 Diagnostic Centers
7.4.1 Diagnostic Centers Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.5 Academic And Research Centers
7.5.1 Academic And Research Centers Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Mammalian polyclonal IgG antibody market share by region, 2022 & 2030
8.2 Global Outlook
8.3 North America
8.3.1 SWOT Analysis
8.3.1.1 North America mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.3.1.2 North America mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.3.1.3 North America mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.3.1.4 North America mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Regulatory Framework
8.3.2.4 Reimbursement Scenario
8.3.2.5 U.S. mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.3.2.6 U.S. mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.3.2.7 U.S. mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.3.2.8 U.S. mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Regulatory Framework
8.3.3.4 Reimbursement Scenario
8.3.3.5 Canada mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.3.3.6 Canada mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.3.3.7 Canada mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.3.3.8 Canada mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4 Europe
8.4.1 SWOT Analysis
8.4.1.1 Europe mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.1.2 Europe mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.1.3 Europe mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.1.4 Europe mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.2 Germany
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Framework
8.4.2.4 Reimbursement Scenario
8.4.2.5 Germany mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.2.6 Germany mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.2.7 Germany mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.2.8 Germany mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.3 U.K.
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Reimbursement Scenario
8.4.3.5 U.K. mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.3.6 U.K. mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.3.7 U.K. mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.3.8 U.K. mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.4 France
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Regulatory Framework
8.4.4.4 Reimbursement Scenario
8.4.4.5 France mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.4.6 France mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.4.7 France mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.4.8 France mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Regulatory Framework
8.4.5.4 Reimbursement Scenario
8.4.5.5 Italy mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.5.6 Italy mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.5.7 Italy mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.5.8 Italy mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Regulatory Framework
8.4.6.4 Reimbursement Scenario
8.4.6.5 Spain mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.6.6 Spain mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.6.7 Spain mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.6.8 Spain mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.7 Denmark
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Regulatory Framework
8.4.7.4 Reimbursement Scenario
8.4.7.5 Denmark mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.7.6 Denmark mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.7.7 Denmark mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.7.8 Denmark mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.8 Sweden
8.4.8.1 Key Country Dynamics
8.4.8.2 Competitive Scenario
8.4.8.3 Regulatory Framework
8.4.8.4 Reimbursement Scenario
8.4.8.5 Sweden mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.8.6 Sweden mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.8.7 Sweden mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.8.8 Sweden mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.4.9 Norway
8.4.9.1 Key Country Dynamics
8.4.9.2 Competitive Scenario
8.4.9.3 Regulatory Framework
8.4.9.4 Reimbursement Scenario
8.4.9.5 Norway mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.4.9.6 Norway mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.4.9.7 Norway mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.4.9.8 Norway mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5 Asia Pacific
8.5.1 SWOT Analysis
8.5.1.1 Asia Pacific mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.1.2 Asia Pacific mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.1.3 Asia Pacific mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.1.4 Asia Pacific mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Regulatory Framework
8.5.2.4 Reimbursement Scenario
8.5.2.5 Japan mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.2.6 Japan mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.2.7 Japan mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.2.8 Japan mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5.3 China
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Reimbursement Scenario
8.5.3.5 China mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.3.6 China mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.3.7 China mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.3.8 China mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5.4 India
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Reimbursement Scenario
8.5.4.5 India mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.4.6 India mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.4.7 India mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.4.8 India mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5.5 South Korea
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Reimbursement Scenario
8.5.5.5 South Korea mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.5.6 South Korea mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.5.7 South Korea mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.5.8 South Korea mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5.6 Australia
8.5.6.1 Key Country Dynamics
8.5.6.2 Competitive Scenario
8.5.6.3 Regulatory Framework
8.5.6.4 Reimbursement Scenario
8.5.6.5 Australia mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.6.6 Australia mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.6.7 Australia mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.6.8 Australia mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.5.7 Thailand
8.5.7.1 Key Country Dynamics
8.5.7.2 Competitive Scenario
8.5.7.3 Regulatory Framework
8.5.7.4 Reimbursement Scenario
8.5.7.5 Thailand mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.5.7.6 Thailand mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.5.7.7 Thailand mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.5.7.8 Thailand mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.6 Latin America
8.6.1 SWOT Analysis
8.6.1.1 Latin America mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.6.1.2 Latin America mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.6.1.3 Latin America mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.6.1.4 Latin America mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.6.2 Brazil
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Regulatory Framework
8.6.2.4 Reimbursement Scenario
8.6.2.5 Brazil mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.6.2.6 Brazil mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.6.2.7 Brazil mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.6.2.8 Brazil mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.6.3 Mexico
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Regulatory Framework
8.6.3.4 Reimbursement Scenario
8.6.3.5 Mexico mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.6.3.6 Mexico mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.6.3.7 Mexico mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.6.3.8 Mexico mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.6.4 Argentina
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Regulatory Framework
8.6.4.4 Reimbursement Scenario
8.6.4.5 Argentina mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.6.4.6 Argentina mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.6.4.7 Argentina mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.6.4.8 Argentina mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.7 MEA
8.7.1 SWOT Analysis
8.7.1.1 MEA mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.7.1.2 MEA mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.7.1.3 MEA mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.7.1.4 MEA mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 Competitive Scenario
8.7.2.2 Regulatory Framework
8.7.2.3 Reimbursement Scenario
8.7.2.4 Argentina mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.7.2.5 Argentina mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.7.2.6 Argentina mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.7.2.7 Argentina mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Key Country Dynamics
8.7.3.2 Competitive Scenario
8.7.3.3 Regulatory Framework
8.7.3.4 Reimbursement Scenario
8.7.3.5 Saudi Arabia mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.7.3.6 Saudi Arabia mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.7.3.7 Saudi Arabia mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.7.3.8 Saudi Arabia mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.7.4 UAE
8.7.4.1 Key Country Dynamics
8.7.4.2 Competitive Scenario
8.7.4.3 Regulatory Framework
8.7.4.4 Reimbursement Scenario
8.7.4.5 UAE mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.7.4.6 UAE mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.7.4.7 UAE mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.7.4.8 UAE mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
8.7.5 Kuwait
8.7.5.1 Key Country Dynamics
8.7.5.2 Competitive Scenario
8.7.5.3 Regulatory Framework
8.7.5.4 Reimbursement Scenario
8.7.5.5 Kuwait mammalian polyclonal IgG antibody market, by type, 2018 – 2030 (USD Million)
8.7.5.6 Kuwait mammalian polyclonal IgG antibody market, by product, 2018 – 2030 (USD Million)
8.7.5.7 Kuwait mammalian polyclonal IgG antibody market, by application, 2018 – 2030 (USD Million)
8.7.5.8 Kuwait mammalian polyclonal IgG antibody market, by end-user, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Participant’s overview
9.1.1 Abcam plc.
9.1.2 Bio-Rad Laboratories
9.1.3 Thermo Fisher Scientific
9.1.4 Novartis AG
9.1.5 Geno Technology Inc.
9.1.6 Merck KGaA
9.1.7 Cell Signaling Technologies
9.1.8 F. Hoffmann-La Roche Ltd
9.1.9 Stemcell Technologies Inc.
9.1.10 Phoenix Pharmaceuticals
9.2 Financial performance
9.3 Participant categorization
9.3.1 Market leaders
9.3.1.1 Mammalian polyclonal IgG antibody market share analysis, 2022
9.3.2 Strategy mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/service launch
9.3.2.5 Partnerships
9.3.2.6 Others

※본 조사보고서 [세계의 포유류 폴리클로널 IgG 항체 시장 (2023~2030) : 마우스, 토끼] (코드 : GRV23MR116) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 포유류 폴리클로널 IgG 항체 시장 (2023~2030) : 마우스, 토끼] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 맞춤형 항체 시장 (2023~2030) : 단클론 항체, 폴리클로날 항체, 재조합 항체, 기타
GRV23MR076 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 맞춤형 항체 시장 규모가 2023년부터 2030년 사이에 CAGR 9.7% 증가하여, 2030년에는 301.7백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는 세계의 맞춤형...Custom Antibody Market Growth & Trends The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during...

글로벌 항체 수탁제조 및 제조 기관 시장 (2023-2030) : 종양학, 신경학, 심장학
GRV23NOV036 / Grand View Research / 2023년 9월 / 글로벌 항체 수탁제조 및 제조 기관 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 항체 수탁제조 및 제조 기관 시장은 2023년부터 2030년까지 연평균 14.0%의 성장률을 보이며 2030년 584억...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 항체 수탁제조 및 제조 기관 시장 변수/동향/범위 Chapter 4. 세계의 항체 수탁제조 및 제조 기관 시장 : 제품별 예측 및 동향 분석 Chapter 5. 세계의 항체 수탁제조 및 제조 기관 시장 : 공급원별 예측 및 동향 분석 Chapter...

세계의 펩티드 마이크로어레이 시장 (2023~2030) : 질환 진단, 단백질 기능 분석
GRV23MA024 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 펩티드 마이크로어레이 시장 규모가 2023년부터 2030년 사이에 연평균 4.51% 성장하여, 2030년에는 1,133.5백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 펩티드 마이크로어레이 시장을...Peptide Microarray Market Growth & Trends The global peptide microarray market size is expected to reach USD 1,133.5 million by 2030, registering a CAGR of 4.51% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate...

세계의 미생물 API 시장 2023-2030 : 호스별 (포유류, 박테리아, 곰팡이), 유형별 (항체, 펩타이드, 단백질), 부위별, 분자별, 최종 용도별, 지역별
GRV24JAN164 / Grand View Research / 2023년 11월 / 글로벌 미생물 API 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 미생물 API 시장 규모는 2030년까지 961억1000만 달러에 달할 것으로 예상되며, 2023년에서 2030년까지 6.66%의 CAGR을 기록할 것으로...1. 조사 방법 및 범위 2. 개요 3. 세계의 미생물 API 시장 변수/동향/범위 4. 세계의 미생물 API 시장 규모 : 호스트별 비즈니스 분석 5. 세계의 미생물 API 시장 규모 : 유형별 비즈니스 분석 6. 세계의 미생물 API 시장 규모 : 사이트별 비즈니스 분석 7. 세계의 미생물 API 시장 규모 :...

세계의 라벨 프리 어레이 시스템 시장 (2023~2030) : 표면 플라즈몬 공명, 생체층 간섭, 세포 유전 분광
GRV23MR110 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 라벨 프리 어레이 시스템 시장 규모가 2023년부터 2030년 사이에 CAGR 7.42% 증가하여, 2030년에는 799.59백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는...Label-free Array System Market Growth & Trends The global label-free array system market size is expected to reach USD 799.59 million by 2030, expanding at a CAGR of 7.42% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial...